THE AMERICAN FOREGUT SOCIETY
Minimally Invasive and Novel Therapeutics (MINT) in Foregut Disease 2021Sept 9-11, 2021
The coordinated care of patients with foregut disease remains challenging. The goal of the MINT Foregut Course, accredited by Harvard Medical School, aims to give clear guidelines to practicing clinicians who manage such patients. This symposium offers an ideal mix of the traditional standard-of-care principles with new, cutting edge information. It explores issues in several areas including medical management, state-of-the-art surgical management, endoluminal therapy and pharmacologic management as well as diet/lifestyle management. Multiple learning modalities will be incorporated into the course to engage the learner in the educational process and help them develop new strategies they can apply in their own practice setting.
For more information: https://cmeregistration.hms.harvard.edu/734807-2201